See Lilly(Eli)'s analyst price targets ($1.3K) vs the current share price.
Get informed when a big investor buys or sells
+ Follow$1,220.51
22 analysts in the last 4 months
High: $1500 | Low: $1119
No recommendations in the last 4 months.
Lilly(Eli) (LLY) currently reports a target price of $1.3K. Use the charts on this page to explore Lilly(Eli)'s target price history and peer comparisons.
Analysts' average 12-month price target for Lilly(Eli) is $1.3K, about 9.4% upside from the current share price of $1220.51. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $1.3K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lilly(Eli), and consider following LLY for alerts when major investors trade the stock.
Lilly(Eli) is classified in the Healthcare sector. On target price, it currently shows $1.3K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LLY with unrelated industries.